Publications

Dr. Murshed’s Publications:

Dr. Weick’s Publications:

  • Weick JK, Kiely JM, Harrison EG, and Carr DT: Pleural Effusion in Lymphoma. Cancer 31:848, 1972.
  • Weick JK: Studies on Leuko-erythroblastosis: Clinical and Experimental. Master’s Thesis, University of Minnesota, 1973.
  • Weick JK: Leuko-erythroblastosis: Diagnostic and Prognostic Significance. Mayo Clin Proc 49:110-113, 1974.
  • Alexanian R, Salmon S, Bonnet J, Gehan E, Haut A, and Weick JK: Chemotherapy for Multiple Myeloma. Recent Advances in Cancer Treatment. Tagnon HJ (ed.), pp. 19-31, Raven Press, NY 1977.
  • Seligman M, Bukowski RM, James K. Weick, M.D. Curriculum Vitae 3 Macroglobulinosis. Arch Dermatol 116:575-577, 1980.
  • Alexanian R, Salmon S, Bonnet J, Gehan E, Haut A, and Weick J: Combination Therapy for Multiple Myeloma. Cancer 40:2765-2771, 1977.
  • Weick JK: Intravascular Coagulation in Cancer. Semin Oncol 5:203-211, 1978.
  • Alexanian R, Gehan E, Haut A, Saiki J, and Weick J: Unmaintained Remissions in Multiple Myeloma. Blood 51:1005-1012, 1978.
  • Weick JK, and Cooperman AM: Ovarian Suppression and Breast Cancer. Surg Clin North Amer 58:795-800, 1978.
  • Hanke CW, Steck WD, Bergfeld WF, Valenzuela R, Weick JK, Young JR, and Gross EG: Cutaneous James K. Weick, M.D. Curriculum Vitae 3 Macroglobulinosis. Arch Dermatol 116:575-577, 1980.
  • Rothmann SA, and Weick JK: Cisplatin Toxicity for Erythroid Precursors. NEngl J Med 304:360, 1981.
  • Weick JK, Jones SE, Haut A, Fisher R, and Dixon DO: The Treatment of Refractory Lymphomas with VBAP. Cancer Treat Rep 65:611-614, 1981.
  • Weick JK, Donovan PB, Najean Y, et al: The Use of Cimetidine for the Treatment of Pruritus in Polycythemia Vera. Arch Intern Med 142:241-242, 1982.
  • Tubbs, RR, Weiss RA, Savage RA, Sebek BA, and Weick JK: Cell Surface Markers in Lymphoproliferative Disease. N Engl J Med 304:1303, 1981 (Letter).
  • Bukowski RM, Hewlett JS, Reimer RR, Groppe CW, Weick JK, and Livingston RB: Therapy of Thrombotic Thrombocytopenic Purpura. Semin Thrombo Hemostas 7:1-8, 1981.
  • Reimer RR, Gahbauer R, Bukowski RM, Hewlett JS, Groppe CW, Weick JK, and Antunez AR: Simultaneous Treatment with Cisplatin and Radiation Therapy for Advanced Solid Tumors: A Pilot Study. Cancer Treat Rep 65:219-222, 1981.
  • Miller TP, Weick JK, Grozea PN, and Carlin DA: Extensive Adenocarcinoma and Large Cell Undifferentiated Carcinoma of the Lung Treated with 5-FU, Vindesine, and Mitomycin (FEMi): A Southwest Oncology Group Study. Cancer Treat Rep 66(3):553-556, 1982.
  • Theodors A, Bukowski RM, Hewlett JS, Livingston RB, and Weick JK: Intermittent Regional Infusion of Chemotherapy for Pancreatic Adenocarcinoma. Am J Clin Oncol:Cancer Clin Trials 5:555-558, 1982.
  • Bukowski RM, Schacter LP, Groppe CW, Hewlett JS, Weick JK, and Livingston RB: Phase II Trial of 5- Fluorouracil, Adriamycin, Mitomycin-C and Streptozotocin (FAM-S) in Pancreatic Carcinoma. Cancer 50:197- 200, 1982.
  • Benjamin J, Tubbs RR, Bergfeld W, Weiss RA, Savage RA, Sebek BA, Weick JK: Cutaneous T-Cell Immunoblastic Sarcoma. Clev Clin Q 50:167-171, 1983.
  • Salmon SE, Haut A, Bonnet J, Amare M, Weick J, Durie BGM, and Dixon D: Alternating Combination Chemotherapy and Levamisole Improves Survival in Multiple Myeloma: A Southwest Oncology Group Study. J Clin Oncol 1:453-461, 1983.
  • Weick JK, Jones SE, and Ryan DH: Phase II Study of 4′-(9-Acridinylamino) Methanesulfon-M-Anisidide (mAMSA) in Advanced Lymphoma: A Southwest Oncology Group Study. Cancer Treat Rep 67:489-492, 1983.
  • Jones SE, Haut A, Weick JK, et al: Comparison of Adriamycin Containing Chemotherapy (MOP-BAP) with MOPP-Bleomycin in the Management of Advanced Hodgkin’s Disease. Cancer 51:1339-1347, 1983. James K. Weick, M.D. Curriculum Vitae 4
  • Weick JK, Stephens RL, Baker LH, and Jones SE: Gallium Nitrate (NSC-15200) in Malignant Lymphoma. Cancer Treat Rep 67:823-825, 1983.
  • Weick JK, Livingston RB, and van Slyck EJ: Colchicine in Refractory Chronic Lymphocytic Leukemia: A Southwest Oncology Group Study. Investigational New Drug, 1:335-338, 1983.
  • Weick JK, Tranum B, and Morrison F: The Treatment of Acute Leukemia with Continuous Infusion L-Alanosine. Investigational New Drugs 1:240-252, 1983.
  • Weick JK, Antunez AR, Kraus T, Fabian C, and Dixon D: Combined Modality Therapy of Non-Hodgkin Lymphoma with CHOP and Total Body Irradiation. Int J Radiat Oncol Biol Phys 9:1205-1207, 1983.
  • Tubbs RR, Fishleder A, Weiss RA, Savage RA, Sebek BA, and Weick JK: Immunohistochemical Cellular Phenotype of Lymphoproliferative Disorders. Am J Pathol 113:207-221, 1983.
  • Bukowski RM, Brown L, Weick JK, Groppe CW, and Purvis J: Combination Chemotherapy of Metastatic Thyroid Cancer. Am J Clin Oncol (CCT) 6:579-581, 1983.
  • Weick JK, Jones SE, Grozea PN, Fabian CJ, and Dixon DO: Vindesine, Carmustine, Doxorubicin, and Prednisone (EBAP) in Recurrent Lymphomas: A Southwest Oncology Group Study. Cancer Treat Rep 68:7-8, 1984.
  • Tubbs RR, Savage RA, Sebek BA, Fishleder A, and Weick JK: Antigenic Phenotype of Splenic Hairy Cells. Am J Med 76:199-205, 1984.
  • Fishleder A, Tubbs RR, Valenzuela R, Weick J, and Norris D: Immunophenotypic Characterization of Acute Leukemia by Immunocytology. Am J Clin Pathol 81:611-617, 1984.
  • Miller ML, Tubbs RR, Fishleder AJ, Savage RA, Sebek BA, and Weick JK: Immunoregulatory T-8 and Leu-7 Lymphocytes in B Cell Follicular Lymphomas. Human Pathol 15:810-817, 1984.
  • Wilke W, Curry T, Tubbs RR, Weiss RA, Savage RA, and Weick J: T Cell Lymphoma Occurring in Sjogren’s Syndrome. Arthritis Rheum 27:951-955, 1984. 35. Rothmann SA, Paul P, Weick JK, McIntyre WR, and Fantelli F: Effect of Cis-Diammine Dichloroplatinum on Erythropoietin Production and Hematopoietic Progenitor Cell. Int J Cell Cloning 3:415-423, 1985.
  • Becker RC, Giuliani M, and Weick JK: Thrombotic Thrombocytopenic Purpura in a Patient with Systemic Lupus Erythematosus. Cleve Clin Q 52:409-415, 1985.
  • Petras RE, Tubbs RR, Gephardt GN, Sebek BA, Golish JA, and Weick JK: T-lymphocyte Proliferation in Lymphomatoid Granulomatosis. Cleve Clin Q 52:137-146, 1985.
  • Weick JK, Rainey JM, Livingston RB, Baker LH, O’Bryan RM, and Cain TT: Treatment of Non-Small Bronchogenic Carcinoma with Vinblastine and Mitomycin: A Southwest Oncology Group Study, Cancer Treat Rep 69:583-586, 1985. James K. Weick, M.D. Curriculum Vitae 5
  • Smith A, Weinstein M, Modic M, Pavlicek W, Rogers L, Budd G, Bukowski R, Purvis J, Weick J, and Duchesneau P: Magnetic Resonance with Marked T2-Weighted Images: Improved Demonstration of Brain Lesions, Tumor, and Edema. Am J NR 6:691-697, 1985.
  • Linden M, Tubbs R, and Weick J: Large Cell Lymphoma with Diffuse Sclerosis. Cleve Clin Q 53:319-322, 1986.
  • Madjlessi SH, Farmer RG, and Weick JK: Inflammatory Bowel Disease and Leukemia: A Report of Seven Cases of Leukemia in Ulcerative Colitis and Crohn’s Disease and Review of the Literature. Dig Dis Sci 31:1025-1031, 1986.
  • Dabich L, Bull FE, Beltran G, Athens JW, Coltman CA, Weick JK, van Slyck EJ, and Amare M: Phase II Evaluation of Aclacinomycin A in Refractory Adult Acute Leukemia. Cancer Treat Rep 70:967-969, 1986.
  • Bukowski RM, Theodors A, Purvis JD, Budd GT, Weick JK, Gahbauer R: Phase II Trial of Sequential Chemotherapy and Low-Dose Radiotherapy in Advanced Gastric Adenocarcinoma. Am J Clin Oncol 10(5):376- 379, 1987.
  • Ryan DH, Kopecky KJ, Head D, Gumbart C, Grever MR, Karanes C, Weick JK and Coltman CA, Jr: Phase II Evaluation of Teniposide and Ifosfamide in Refractory Adult Acute Lymphocytic Leukemia: A Southwest Oncology Group Study. Cancer Treat Rep 71:713-716, 1987.
  • Weick JK: Overview of CCF Research. Innovations in Oncology. Nov. 1987. (Edited issue on Cleveland Clinic).
  • Becker RC, Giuliani M, Savage RA and Weick JK: Massive Hemolysis in Clostridium Perfringens Infections. J Surg Oncol 35:13-18, 1987.
  • Vijayakumar S, Shepard K, Thomas F, Weick J, Rice T, Mehta A: Role of Radiation Therapy in Small Cell Lung Cancer – A Bio-Clinico-Pathological Review and Perspective. Journal of the National Med Assoc 79:496-504, 1987.
  • Pugh RP, Fleming T, Guy JT, Weick JK, Ward JH: Phase II Study of Diaziquone in Untreated Advanced Gastric Carcinoma: A Southwest Oncology Group Study. Am J Clin Oncol: Cancer Clin Trials 12:11-13, 1988.
  • Cowan JD, Green S, Lucas J, Weick JK, Balcerzak SP, Rivkin SE, Coltman CA, Baker LH: Phase II Trial of 5- Day Intravenous-Infusion Vinblastine Sulfate in Patients with Diffuse Malignant Mesothelioma: A Southwest Oncology Group Study. Investigational New Drugs 6:247-248, 1988.
  • Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI: Southwest Oncology Group Clinical-Trials for Intermediate-Grade and High-Grade Non-Hodgkin’s Lymphomas. Seminars in Hematology 25:17-22, 1988.
  • Miller RL, Bukowski RM, Budd GT, Purvis JP, Weick JK, Shepard KV, Midha KK, Ganapathi R: Clinical Modulation of Doxorubicin Resistance by the Calmodulin-Inhibitor, Trifluoperazine: Phase I/II Trial. J Clin Oncol 6:880-888, 1988. James K. Weick, M.D. Curriculum Vitae 6
  • Coltman CA, Dahlberg S, Jones SE, Miller TP, Dana BW, Weick JK, McKelvey EM, Hartsock RJ, Dixon DO: Southwest Oncology Group Studies in Diffuse Large Cell Lymphoma: A Subset Analysis. Cancer Chemotherapy: Challenges for the Future 3:194-201, 1988.
  • Paganini EP, Garcia J, Abdulhadi M, Lathim D, Giesman J, Weick JK: The Anemia of Chronic Renal Failure. Cleveland Clinic Journal of Medicine 56:79-86, 1989.
  • Hussein HL, Dahlberg S, Head D, Waddell CC, Dabich L, Weick JK, Morrison F, Saiki JH, Metz E, Rivkin SE, Grever MR, Boldt D: Treatment of Acute Lymphoblastic Leukemia in Adults with Intensive Induction, Consolidation, and Maintenance Chemotherapy. Blood 73:57-63, 1989.
  • Didich J, Weick JK: The Development of a Palliative Care Program. Cleve Clin J Med 56:762-764, 1989.
  • Pugh RP, Fleming T, Guy JT, Weick JK, Ward JH: Phase II Study of Diaziquone in Untreated Advanced Gastric Carcinoma. Am J Clin Oncol (CCT) 12(1):11-13, 1989.
  • Miller RL, Purvis JP III, Weick JK: Familial Polycythemia Vera. Cleve Clin J Med 56:813-818, 1989.
  • Wolff SN, Herzig RH, Fay JW, LeMaistre CF, Brown RA, Frei-Lahr D, Strandjord S, Giannone L, Coccia P, Weick JK, Rothmann SA, Krupp KR, Lowder J, Bolwell B, Herzig GP: High-Dose N,N’,N”- Triethylenethiophosphoramide (Thiotepa) with Autologous Bone Marrow Transplantation: Phase I Studies. Semin Oncol 17 (suppl 3): 2-6, 1990.
  • Budd G, Jayaraj A, Grabowski D, Adelstein D, Bauer L, Boyett J, Bukowski R, Murthy S, Weick J: Phase I Trial of Dipyridamole with 5-Fluorouracil and Folinic Acid. Cancer Res 50:7206-7211, 1990. 60. Miller TP, Dahlberg S, Weick JK, Files JC, Eyre HJ, Pendergrass KB, Fisher RI: Unfavorable Histologies of NonHodgkin’s Lymphoma Treated with ProMACE-CytaBOM: A Groupwide Southwest Oncology Group Study. J Clin Oncol 8:1951-1958, 1990. 61. Von Hoff DD, Blumenstein BA, Pollock TW, Crawford ED, Weick JK, Guy JT, Eisenberger M, Fletcher WS, Natale RB: Methylglyoxal Bis-Guanylhydrazone in Advanced Bladder Cancer. Eur J Cancer 26:7:848-849, 1990.
  • Miller TP, Dahlberg S, Weick JK, Files JC, Eyre HJ, Pendergrass KB, Fisher RI: Unfavorable Histologies of NonHodgkin’s Lymphoma Treated with ProMACE-CytaBOM: A Groupwide Southwest Oncology Group Study. J Clin Oncol 8:1951-1958, 1990.
  • Von Hoff DD, Blumenstein BA, Pollock TW, Crawford ED, Weick JK, Guy JT, Eisenberger M, Fletcher WS, Natale RB: Methylglyoxal Bis-Guanylhydrazone in Advanced Bladder Cancer. Eur J Cancer 26:7:848-849, 1990.
  • Radich JP, Kopecky KJ, Willman CL, Weick JK, Head D, Appelbaum F, Collins SJ: N-ras Mutations in Adult de novo Acute Myelogenous Leukemia: Prevalence and Clinical Significance. Blood 76 (4):801-807, 1990.
  • Budd G, Green S, Baker L, Hersh E, Weick J, Osborne K: Phase II Trial of Recombinant Tumor Necrosis Factor in Metastatic Breast Cancer: A Southwest Oncology Group Study. Cancer 68:1694-1695, 1991.
  • Weick J, Crowley J, Natale R, Hom B, Rivkin S, Coltman C, Taylor S, Livingston R: A Randomized Trial of Five Cisplatin-Containing Treatments in Patients with Metastatic Non-Small Cell Lung Cancer: A Southwest Oncology Group Study. J Clin Oncol 9:1157-1162, 1991. James K. Weick, M.D. Curriculum Vitae 7
  • Weick J, Dahlberg S, Fisher R, Dana B, Miller T, Balcerzak S, Pierce H: Combination chemotherapy in intermediate-grade and high-grade Non-Hodgkin’s Lymphoma with MACOP-B: A Southwest Oncology Group Study. J Clin Oncol 9:748-753, 1991.
  • Dabich L, Dahlberg S, Hartsock RJ, LoBuglio AF, Liepman MK, Grozea PN, Eyre HJ, Weick JK, Bonnet JD, Coltman CA, Fisher RI: Alternated versus Syncopated CHOP-PVB: Two Studies for the Treatment of NonHodgkin’s Lymphoma by the Southwest Oncology Group. Cancer Investigation 9(6):613-620, 1991.
  • Rogers LR, Duchesneau PM, Nunez G, Fishleder AJ, Weick JK, Bauer LF, Boyett JM: Comparison of Cisternal and Lumbar CSF Examination in Leptomeningeal Metastasis. Neurology 42:1239-1241, 1992
  • Segal G, Mesa M, Fishleder A, Stoler M, Weick J, Lichtin A, Tubbs R: Precursor Langerhans Cell Histiocytosis, an Unusual Histiocytic Proliferation in a Patient with Persistent Non-Hodgkin Lymphoma and terminal Acute Monocytic Leukemia. Cancer 70:547-553, 1992.
  • Anagrelide Study Group: Anagrelide, A Therapy for Thrombocythemia States: Experience in 577 patients. Am J Med 92:69-76, 1992.
  • Grunberg SM, Crowley J, Livingston R, Gill I, Williamson SK, O’Rourke T, Braun T, Marshall ME, Weick JK, Balcerzak SP, Martino RL: Extended Administration of Oral Etoposide and Oral Cyclophosphamide for the Treatment of Advanced Non-Small Cell Lung Cancer: A Southwest Oncology Group Study. J Clin Oncol 11:1598- 1601, 1993.
  • Rogers LR, Weick JK, Duchesneau P, et. al.: Leptomeningeal Metastases. Neurology 43:450, 1993.
  • Budd GT, Metch B, Weiss SAW, Weick JK, Fabian C, Stephens RL, Balcerzak SP: Phase II Trial of Ifosfamide & Cisplatin in the Treatment of Metastatic Sarcomas: A Southwest Oncology Group Study. Cancer Chemother Pharamacol 31 (Suppl 2):5213-5216, 1993.
  • Elias L, Stock-Novack D, Head DR, Grever MR, Weick JK, Chapman RA, Godwin JE, Metz EN, Appelbaum FR: A Phase I Trial of Fludarabine Mono Phosphate and Chlorambucil in Chronic Lymphocytic Leukemia. A Southwest Oncology Group Study. Leukemia 7(3):361-365, 1993.
  • Budd GT, Ganapathi R, Bauer L, Murthy S, Adelstein D, Weick JK, et. al.: A Phase I Study of WR-2721 and Carboplatin. Eur J Cancer 29A #8:1122-1127, 1993. 75. Weick JK: New Trends in Oncology. Broward County Med. Assoc., The Record:pp 11, 28 Sept 93.
  • Barlogie B, Crowley J, Salmon SE, Bonnet J, Weick JK, Hayden K: Phase II Study of Carboplatin (CBDCA) in Refractory Multiple Myeloma. A Southwest Oncology Group Study. Investigational New Drugs 12:53-55, 1994.
  • Rice TN, Adelstein DJ, Kirby TJ, Saltarelli MG, Murthy SR, Van Kirk MA, Wiedemann HP, and Weick JK: Aggressive Multimodality Therapy for Malignant Pleural Mesothelioma. Am Thorac Surg 1994;58:24-29. James K. Weick, M.D. Curriculum Vitae 8
  • Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi III AT, Weick JK, et al: Concurrent Cisplatin/Etoposide Plus Chest Radiotherapy Followed by Surgery for Stages IIIA(N2) and IIIB Non-Small-Cell Lung Cancer: Mature Results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol 13:1880-1892, 1995.
  • Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Blood 1995 Sep 15;86(6):2329-2342.
  • Head D, Kopecky KJ, Weick J, Files JC, Ryan D, Foucar K, Montiel M, et al. Effect of Aggressive Daunomycin Therapy on Survival in Acute Promyelocytic Leukemia. Blood 1995;86(5):1717-1728
  • Weick J, Kopecky KJ, et al: A Randomized Investigation of High-Dose Versus Standard-Dose Cytosine Arabinoside With Daunorubicin in Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study. Blood,Vol 88, No 8 (October 15),1996: pp 2841- 2851
  • Weick J, Crowley J, Natale RB, Hom BL, Rivkin s, Coltman CA, Taylor SA, Livingston RB. A Randomized Trial of Five Cisplatin-containing Treatments in Patients with Metastatic Non-small Cell Lung Cancer: A Southwest Oncology Group Study. Classic Papers and Current Comments 2(1):172-177, 1997.
  • Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi III AT, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, Fosmire H, Taylor SA, Stelzer KJ, Beasley KR, Livingston RB. Concurrent Cisplatin/etopiside Plus Chest Radiotherapy Followed By Surgery For Stages IIIA(N2) and IIIB Non-small Cell Lung Cancer: Mature results of Southwest Oncology Group Phase II Study 8805. Classic Papers and Current Comments 2(1):145-158, 1997.
  • Li Q, Kopecky K, Mohan A, Willman C, Appelbaum F, Weick J and Issa JP. Estrogen Receptor Methylation is Associated With Improved Survival in Adult Acute Myeloid Leukemia. Clin Cancer Res. Accepted Feb 1999.
  • Weick J, Crowley J, Hussein M, Moore D, Barlogie B. The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study. Investigational New Drugs 2002; 20:117-121
  • Justice G, Kessler JF, Jadeja J, Campos L, Weick J et al. A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia. Ann Oncol. 2005 Jul;16(7):1192-8.
  • Winter JN, Weller EA, Horning SJ, Krajewska M, Variakojis D, Haberman TM, Fisher RI, Kurtin PJ, Macon WR, Chhanabhai M, Felgar RE, His ED, Medeiros J, Weick JK, Reed JC and Gascoyne RD. Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study, Blood 2006; 107: 4207-4213
  • Winter JN, Shuli Li, Aurora V, Variakojis D, Nelson B,Krajewska M, Zhang L, Haberman TM, Fisher RI, Macon WR, Chhanabhai M, Felgar RE, His ED, Medeiros LJ, Weick JK, Weller EA, Melnick A, Reed JC, Horning SJ, and Gascoyne RD. Expression of p21 Protein Predicts Outcome in DLBCL Patients Older Than 60 years Treated with R-CHOP: A Prospective ECOG and SWOG Correlative Study on E4494. Clin Cancer Res; 2010 ;16(8);2435-42